Example of stool diary used, based on the Bristol Stool Form Scale

Ching Lam; Wei Tan; Matthew Leighton; Margaret Hastings; Melanie Lingaya; Yirga Falcone; Xiaoying Zhou; Luting Xu; Peter Whorwell; Andrew F Walls; Abed Zaitoun; Alan Montgomery; Robin C Spiller

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Lam C, Tan W, Leighton M, et al. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial. Southampton (UK): NIHR Journals Library; 2015 Mar. (Efficacy and Mechanism Evaluation, No. 2.2.)

Cover of Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial.

Show details

Contents

< Prev Next >

Appendix 4Example of stool diary used, based on the Bristol Stool Form Scale

(PDF download)

Stool diary

TABLE 18

Summary of number of days with stool diary entered at baseline and 11–12 weeks

Stool diary	Number of days with stool diary recorded, mean (SD); median (IQR)
Baseline	13.9 (0.3); 14 (14–14)
11–12 weeks	13.8 (1.2); 14 (14–14)

Copyright © Queen’s Printer and Controller of HMSO 2015. This work was produced by Lam et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Included under terms of UK Non-commercial Government License.

Bookshelf ID: NBK280110

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Lam C, Tan W, Leighton M, et al. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial. Southampton (UK): NIHR Journals Library; 2015 Mar. (Efficacy and Mechanism Evaluation, No. 2.2.) Appendix 4, Example of stool diary used, based on the Bristol Stool Form Scale.
PDF version of this title (4.8M)

Other titles in this collection

Efficacy and Mechanism Evaluation

Recent Activity

Clear Turn Off Turn On

Example of stool diary used, based on the Bristol Stool Form Scale - Efficacy an...
Example of stool diary used, based on the Bristol Stool Form Scale - Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf